US Stock MarketDetailed Quotes

OBIO Orchestra BioMed

Watchlist
  • 4.710
  • -0.240-4.85%
Close May 10 16:00 ET
  • 4.710
  • 0.0000.00%
Post 16:02 ET
168.51MMarket Cap-3430P/E (TTM)

Orchestra BioMed Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Orchestra BioMed Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

262.00K

-76.25%
EPS(YoY)

-0.37

-19.97%
Analyst Rating

Buy

Apr 30, 2024

Orchestra BioMed Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 603.000K--
--2024/Q1-- / 580.000K--
--2023/Q4262.000K / 994.500K--
--2023/Q3419.000K / 895.000K--
--2023/Q2915.000K / 706.000K--
--2023/Q11.164M / 680.000K--
--2022/Q41.103M / 1.180M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 603.000K--
--2024/Q1-- / 580.000K--
--2023/Q4262.000K / 994.500K--
--2023/Q3419.000K / 895.000K--
--2023/Q2915.000K / 706.000K--
--2023/Q11.164M / 680.000K--
--2022/Q41.103M / 1.180M--
--------
--------
--------

Unlock Free Earnings Estimates

Orchestra BioMed Earnings Reports

  • Orchestra BioMed | 10-K: Annual report

    Mar 27 16:10 ET

  • Orchestra BioMed | 10-Q: Quarterly report

    Nov 13, 2023 16:10 ET

  • Orchestra BioMed | 10-Q: Q2 2023 Earnings Report

    Aug 10, 2023 16:06 ET

  • Orchestra BioMed | 10-Q: Quarterly report

    May 12, 2023 09:04 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 30, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg